The user facility reported that stock from (b)(6); the capiox failed within 3 min of bypass starting.Device was not oxygenating; did manual blood gas as confirmation.They stopped the bypass, and the oxygenator was changed out, and was worked fine.There was no harm to the patient.
|
This report is being submitted as follow up no.1 to provide corrections to sections d4 and g5; to update section d10, h3, and to provide the completed investigation.Upon receipt of the actual sample, it was found to be a cx*fx05rw, not the initially reported cx*fx25rw.The involved device was confirmed to be cx*fx05rw, therefore, has been corrected.G5.Pma/510(k): k130280.The actual sample was received for evaluation.Visual inspection revealed a crack on the blood outlet port and a scratch on the blood inlet port on the oxygenator module.There was not any other anomaly, such as a break, in the appearance on the remainders of the device.The actual sample, after having been rinsed and dried, was built into a circuit with tubes and tested for its gas transfer performance in accordance with the factory's shipping inspection protocol.Bovine blood arranged to (hb12.0 g/dl, temp.37oc., ph:7.4, svo2:65% and pvco2:45mmhg) was circulated in the oxygenator module under the following conditions: @ v/q=1, fio2=100% and the flow rate of 2l/min.And 1/min.Result: o2 transfer volume: @2l/min.= 121ml/min.@1l/min.= 69ml/min.Co2 removal volume: @2l/min.= 104ml/min.@1l/min.= 56ml/min.No anomalies were revealed in the gas transfer performance of the actual sample, with the obtained values meeting manufacturer specifications.Based on the provided information and investigation results, there is no definitive evidence that this event was related to a device defect or malfunction.The investigation results verified the returned sample was of the normal product with no issue in the gas transfer performance.However, the exact cause of the reported event cannot be definitively determined based on the available information.
|